Deep sedation with remimazolam plus ketamine during atrial fibrillation ablation is linked to fewer clinically relevant ...

Patients with a high probability of HFpEF may experience greater benefits from atrial fibrillation ablation than those with a ...

The "Left Atrial Appendage Closure (LAAC) Market - A Global and Regional Analysis: Focus on Procedure, Product, End User, and Region - Analysis and Forecast, 2025-2035" report has been added to ...

SGLT2 inhibitors, compared with GLP1 agonists, significantly lower risk for atrial fibrillation in patients with type 2 diabetes.

Abbott has reported new data from its prospective, non-randomised Volt CE Mark Study, indicating that individuals treated with pulsed field ablation (PFA) therapy using the Volt PFA System for atrial ...

Breast cancer is the most common cancer among women in several countries around the world, including Japan, where 1 in 9 ...

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

A study was conducted to compare clinical outcomes between NOAC vs VKA therapy for stroke prevention in patients with AF and ...

For patients newly diagnosed with atrial fibrillation (AF) during hospitalization for other causes, most are not dispensed ...

Dr. Paul Dorian, MD, CM, MSc., Cardiologist, discusses atrial fibrillation treatment options.

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.